Medicine
Heparin 1000 units/mL injection
Heparin 1000 units/mL injection is a generic prescription medicine for intravenous, subcutaneous use, made by 18 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Heparin
- Brand
- Sold under the generic name
- Strength
- 1000 units/mL
- Dosage form
- Injection
- Route
- Intravenous, subcutaneous
- Packs
- 25 vials, 1 vial and 43 more
- Manufacturers
- Gland PharmaIndiaSagent PharmaceuticalsFresenius KabiMeitheal PharmaceuticalsHepalinkMedical Purchasing SolutionsSandozHospiraNorthStar RxLLCBE Pharmaceuticals18 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AB01 Heparin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 February 1972
- Identifiers
- RxCUI 1361226, 1658647, 1361574 +7DailyMed set ID 4c118b39-cb4e-31a9-e063-6394a90a41b0, 41dd053d-49f6-4eb1-b9e7-3508ede82df8, 1c634e53-44d6-cdcd-e063-6294a90a92e9 +25NDC 71872-7365, 72603-336, 0781-3555 +34Application ANDA202957, ANDA211005, ANDA202732 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 18 labelers. The register lists 46 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 68083-427-25 | Gland PharmaIndia | 18 November 2019 |
| 25 vial, multi-dose in 1 carton / 30 mL in 1 vial, multi-dose | 68083-428-25 | Gland PharmaIndia | 18 November 2019 |
| 25 vial in 1 tray / 1 mL in 1 vial | 63323-540-13 | Fresenius Kabi | 4 November 2019 |
| 25 vial in 1 tray / 10 mL in 1 vial | 63323-540-15 | Fresenius Kabi | 4 November 2019 |
| 25 vial in 1 tray / 30 mL in 1 vial | 63323-540-36 | Fresenius Kabi | 4 November 2019 |
| 25 vial, multi-dose in 1 tray / 10 mL in 1 vial, multi-dose | 63323-540-67 | Fresenius Kabi | 25 March 2020 |
| 25 vial in 1 tray / 1 mL in 1 vial | 65219-066-10 | Fresenius Kabi | 22 March 2022 |
| 25 vial, multi-dose in 1 carton / 1 mL in 1 vial, multi-dose | 0781-3538-25 | Sandoz | 16 September 2024 |
| 25 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 0781-3540-25 | Sandoz | 16 September 2024 |
| 25 vial, multi-dose in 1 carton / 30 mL in 1 vial, multi-dose | 0781-3543-25 | Sandoz | 16 September 2024 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 0781-3555-25 | Sandoz | 16 September 2024 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 71288-400-03 | Meitheal Pharmaceuticals | 15 June 2019 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 71288-402-02 | Meitheal Pharmaceuticals | 15 June 2019 |
| 25 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 71288-402-11 | Meitheal Pharmaceuticals | 15 June 2019 |
| 25 vial, multi-dose in 1 carton / 30 mL in 1 vial, multi-dose | 71288-402-31 | Meitheal Pharmaceuticals | 15 June 2019 |
| 25 vial, multi-dose in 1 carton / 1 mL in 1 vial, multi-dose | 71288-449-02 | Meitheal Pharmaceuticals | 2 July 2025 |
| 25 vial in 1 carton / 1 mL in 1 vial | 25021-400-01 | Sagent Pharmaceuticals | 6 July 2010 |
| 25 vial in 1 carton / 10 mL in 1 vial | 25021-400-10 | Sagent Pharmaceuticals | 6 July 2010 |
| 25 vial in 1 carton / 30 mL in 1 vial | 25021-400-30 | Sagent Pharmaceuticals | 6 July 2010 |
| 25 vial in 1 carton / 1 mL in 1 vial | 25021-400-66 | Sagent Pharmaceticals | 1 July 2014 |
| 25 vial in 1 carton / 10 mL in 1 vial | 25021-400-67 | Sagent Pharmaceticals | 1 July 2014 |
| 25 vial in 1 carton / 30 mL in 1 vial | 25021-400-68 | Sagent Pharmaceticals | 1 June 2024 |
| 25 vial in 1 carton / 2 mL in 1 vial | 25021-401-02 | Sagent Pharmaceuticals | 6 July 2010 |
| 25 vial, multi-dose in 1 carton / 1 mL in 1 vial, multi-dose | 81952-112-06 | Hepalink | 12 June 2014 |
| 25 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 81952-112-09 | Hepalink | 12 June 2014 |
| 25 vial, multi-dose in 1 carton / 30 mL in 1 vial, multi-dose | 81952-112-10 | Hepalink | 12 June 2014 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 81952-115-07 | Hepalink | 12 June 2014 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 71839-117-25 | BE Pharmaceuticals | 29 December 2020 |
| 25 vial in 1 package / 1 mL in 1 vial | 0641-0391-12 | Hikma Pharmaceuticals | 22 March 1972 |
| 25 vial, single-dose in 1 tray / 1 mL in 1 vial, single-dose | 0409-2720-01 | Hospira | 31 August 2009 |
| 25 vial, multi-dose in 1 tray / 10 mL in 1 vial, multi-dose | 0409-2720-02 | Hospira | 31 August 2009 |
| 25 vial, multi-dose in 1 tray / 30 mL in 1 vial, multi-dose | 0409-2720-03 | Hospira | 31 August 2009 |
| 25 vial in 1 container / 2 mL in 1 vial | 0069-0043-01 | Pfizer Laboratories | 21 July 2011 |
| 25 vial in 1 tray / 10 mL in 1 vial | 81565-203-02 | Phlow | 7 March 2022 |
| 1 vial, multi-dose in 1 bag / 10 mL in 1 vial, multi-dose | 71872-7351-1 | Medical Purchasing Solutions | 7 May 2025 |
| 1 vial, multi-dose in 1 bag / 30 mL in 1 vial, multi-dose | 71872-7352-1 | Medical Purchasing Solutions | 7 May 2025 |
| 1 vial in 1 bag / 30 mL in 1 vial | 71872-7364-1 | Medical Purchasing Solutions | 9 December 2025 |
| 1 vial, multi-dose in 1 bag / 10 mL in 1 vial, multi-dose | 71872-7365-1 | Medical Purchasing Solutions | 20 February 2026 |
| 25 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 72603-179-25 | NorthStar RxLLC | 1 April 2024 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 72603-234-25 | NorthStar RxLLC | 1 April 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 9 February 1939 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Heparin
Clinical summary
Heparin is an anti-coagulant indicated for prophylaxis and treatment of venous thrombosis and pulmonary embolism,, among other approved uses. It is available as injection for intravenous and subcutaneous use. MedsAcross supplies Heparin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about HeparinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Heparin Sodium prescribing information (Fresenius Kabi) · U.S. National Library of Medicine, DailyMed
Need Heparin 1000 units/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.